Diabetes Canada clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes ;42 suppl 1 :S1-S Accessed 19 April Diabetes Care ; Changes in diabetes-related complications in the United States, N Engl J Med ; Thrasher J. Pharmacologic management of type 2 diabetes mellitus: Available therapies. Am J Cardiol ;S4-S Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes.
Diabetes Care ;36 suppl 2 :SS Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The relationship of glycemic exposure HbA1c to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes ; Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes UKPDS 35 : Prospective observational study. BMJ ; Determinants of retinopathy progression in type 1 diabetes. Am J Med ; Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: A meta-analysis of individual participant data from randomised controlled trials.
Lancet Diabetes Endocrinol ; Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial.
Lancet ; Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes UKPDS Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med ; Effects of medical therapies on retinopathy progression in type 2 diabetes. Effects of intensive glucose lowering in type 2 diabetes. Glucose control and vascular complications in veterans with type 2 diabetes.
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. Pharmacologic management of type 2 diabetes: interim update. Can J Diabetes ; American Diabetes Association. Standards of medical care in diabetes— Diabetes Care ;41 suppl 1 :S1-S Management of hyperglycaemia in type 2 diabetes, A patient-centred approach. Diabetologia ; Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.
Liraglutide and cardiovascular outcomes in type 2 diabetes. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes.
Canagliflozin and cardiovascular and renal events in type 2 diabetes. Guidelines and Protocols Advisory Committee.
Diabetes care. Accessed 2 April Therapeutics Initiative. CMAJ ; suppl 8 :S Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus. Ann Intern Med ; CMAJ ;E External review of guidelines.
Revised March Intravenous IV iron for severe iron deficiency. Is prescribing information from sales representatives balanced? Management of type 2 diabetes. Diabetes Canada. Formulary listings for diabetes medications in Canada April Province of British Columbia. Drug coverage. Glibenclamide vs gliclazide in type 2 diabetes of the elderly. Diabet Med ; Drouin P. Diamicron MR once daily is effective and well tolerated in type 2 diabetes a double-blind, randomized, multinational study.
J Diabetes Complications ; Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev ; Canadian Agency for Drugs and Technologies in Health. Common Drug Review. Glycemic targets in type 2 diabetes.
The limitations and potential hazards of using surrogate markers. Self-monitoring of blood glucose in type 2 diabetes. New drugs III. Gliclazide for type 2 diabetes mellitus. Therapeutics Letter October Questioning the basis of approval for non-insulin glucose lowering drugs. Drugs to avoid.
Diabetes mellitus and cardiovascular disease: An evidence based review of provincial formulary coverage. Dr Clement is a family physician in the Interior of British Columbia with a consulting practice in diabetes. She has been actively involved with Diabetes Canada and was a member of the expert committee, steering committee, and executive committee during development of the , , , and Diabetes Canada clinical practice guidelines. Dr Paty is an endocrinologist and UBC clinical associate professor who specializes in diabetes and post-transplant endocrinology. He was actively involved with the Diabetes Canada guidelines — and with the BC guidelines — Dr Mudaliar is a Vancouver family physician.
Dr Shu is an endocrinologist at Royal Columbian Hospital, currently serving as the regional head of endocrinology for the Fraser Health Authority. Above is the information needed to cite this article in your paper or presentation. Solid-organ transplantation in HIV-infected patients. N Engl J Med. The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in to establish guidelines for the format of manuscripts submitted to their journals.
Clinical practice guidelines were initially developed within the context of evidence-based medicine with the goal of putting medical research findings into practice. However, physicians do not always follow them, even when they seem to apply to the particular patient they have to treat.
This phenomenon, known as clinical inertia, represents a significant obstacle to the efficiency of care and a major public health problem, the extent of which is demonstrated in this book. An analysis of its causes shows that it stems from a discrepancy between the objective, essentially statistical nature of evidence-based medicine on the one hand and the physician's own complex, subjective view referred to here as "medical reason" on the other.
This book proposes a critique of medical reason that may help to reconcile the principles of evidence-based medicine and individual practice. From the book reviews: "The audience is extremely broad, including clinicians, patients, educators, research psychologists, and everyone, including perhaps insurance actuaries, who have an interest in improving patient care outcomes.
This is a well-studied and thought-out book that is outstandingly thought provoking.
Every clinician can identify with many of these issues. Carr, Doody's Book Reviews, March, Help Centre.
Track My Order. My Wishlist Sign In Join. Be the first to write a review. Add to Wishlist. Ships in 15 business days.
Clinical practice guidelines were initially developed within the context of evidence-based medicine with the goal of putting medical research findings into . Editorial Reviews. Review. From the book reviews: “The audience is extremely broad, including.
Link Either by signing into your account or linking your membership details before your order is placed. Description Table of Contents Product Details Click on the cover image above to read some pages of this book! Industry Reviews From the book reviews: "The audience is extremely broad, including clinicians, patients, educators, research psychologists, and everyone, including perhaps insurance actuaries, who have an interest in improving patient care outcomes.